pharmaceutical advertising
The following articles have the tag pharmaceutical advertising
GPs face Medical Director fee hike after ad removal
GPs relying on Medical Director for their prescribing software will face annual subscription fee hikes of at least 50%, as the company moves to recoup the costs of pulling pharmaceutical company advertising from its product. And, in a move likely to disappoint part-time GPs, Health Communication Network (HCN) – which produces the software – has also announced it will no longer offer a discounted rate to part-timers, opting instead for a flat rate. HCN CEO John Frost attributed the price increase to intense lobbying for an advertising withdrawal by the RACGP, AMA and the National Prescribing Service. ...
Debate over GP clinical software ads intensifies
THE company that created Medical Director, the most widely used patient management and prescribing software, has rejected calls to strip pharmaceutical advertising from its products, claiming such a move would result in GPs paying more for the software. In a submission to the Medicines Australia Code of Conduct Review, the AMA called for an end to advertising in prescribing software. “The AMA is opposed to the use of [this] material in prescribing software because of its potential to interfere with the doctor-patient relationship during consultations,” said Associate Professor John Gullotta, chair of the AMA Therapeutics Committee. The ...
